These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5735401)

  • 1. 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agent. V. Therapy of an experimental Salmonella choleraesuis infection iswine.
    Layton HW; Bachmann HJ; Kemp GA; Gale GO; Kiser JS
    Antimicrob Agents Chemother (Bethesda); 1968; 8():528-33. PubMed ID: 5735401
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agents. IV. Activity in mice and chicks.
    Bachmann HJ; Shirk RJ; Layton HW; Kemp GA
    Antimicrob Agents Chemother (Bethesda); 1968; 8():524-7. PubMed ID: 4898539
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agent. IX. Action against hemoflagellate infections in laboratory animals.
    Burden EJ; Racette E
    Antimicrob Agents Chemother (Bethesda); 1968; 8():545-7. PubMed ID: 5735405
    [No Abstract]   [Full Text] [Related]  

  • 4. 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial age. VI. Antibacterial efficacy in mice and in vitro.
    Redin GS; Kuck NA; Forbes M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():534-7. PubMed ID: 5735402
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agent. 8. Antiamoebic activity in vivo of the hydrochloride salt.
    Carvajal S; Pidacks S; Steinmann H; Maxon H; Wozniak A
    Antimicrob Agents Chemother (Bethesda); 1968; 8():541-4. PubMed ID: 5735404
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agent. VII. Action against subcutaneous Trichomonas vaginalis infections in mice.
    Burden EJ; Schumacher E; Kelly M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():538-40. PubMed ID: 5735403
    [No Abstract]   [Full Text] [Related]  

  • 7. The chemotherapy of experimental Salmonella choleraesuis infetion in mice.
    Chung GT; Frost AJ
    J Med Microbiol; 1970 May; 3(2):303-11. PubMed ID: 5452463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapeutic effectiveness of preparation B-40 in experimental staphylococcal infection].
    Pavliĭ SI; Danileĭchenko VV; Kishko IaG; Romanov NN
    Mikrobiol Zh (1978); 1989; 51(1):95-7. PubMed ID: 2725358
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3, 4-thiadiazole: a new antimicrobial agent.
    Berkelhammer G; Asato G
    Science; 1968 Dec; 162(3858):1146. PubMed ID: 4880722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmonella choleraesuis endocarditis.
    Cohen JI
    N C Med J; 1984 Jul; 45(7):431-3. PubMed ID: 6589489
    [No Abstract]   [Full Text] [Related]  

  • 11. Extraintestinal focal infections in adults with Salmonella enterica serotype Choleraesuis bacteremia.
    Chen PL; Wu CJ; Chang CM; Lee HC; Lee NY; Shih HI; Lee CC; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2007 Jun; 40(3):240-7. PubMed ID: 17639165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis.
    Ko WC; Yan JJ; Yu WL; Lee HC; Lee NY; Wang LR; Chuang YC
    Clin Infect Dis; 2005 Jan; 40(2):315-8. PubMed ID: 15655754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertional mutation of marA vitiates inducible multiple antimicrobial resistance in Salmonella enterica subsp. enterica serovar Choleraesuis.
    Tibbetts RJ; Lin TL; Wu CC
    Vet Microbiol; 2005 Aug; 109(3-4):267-74. PubMed ID: 16006078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of hetacillin in pediatrics].
    Gaudier B; Ryckewaert P; Giard P
    Lille Med; 1971 Dec; 16(10):Suppl 5:1486-9. PubMed ID: 5142823
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of furazolidone in salmonelloses of adults].
    Suchert G; Langsch HG; Zastrow R; Schulze H
    Dtsch Gesundheitsw; 1965 Dec; 20(52):2308-10. PubMed ID: 5885810
    [No Abstract]   [Full Text] [Related]  

  • 16. Endogenous endophthalmitis due to Salmonella choleraesuis in an HIV-positive patient.
    Yodprom R; Pathanapitoon K; Kunavisarut P; Ausayakhun S; Wattananikorn S; Rothova A
    Ocul Immunol Inflamm; 2007; 15(2):135-8. PubMed ID: 17558841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem.
    Jean SS; Lee YT; Guo SM; Hsueh PR
    J Infect; 2005 Oct; 51(3):e163-5. PubMed ID: 16230198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with potassium hetacillin 9versapen 'Bristol') against dysentery, dysentery-like salmonellosis].
    Tsunoda O; Yamamoto T; Murata N
    Jpn J Antibiot; 1970 Aug; 23(4):390-5. PubMed ID: 5312789
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacteremia caused by Salmonella enterica serotype Choleraesuis in Taiwan.
    Jean SS; Wang JY; Hsueh PR
    J Microbiol Immunol Infect; 2006 Oct; 39(5):358-65. PubMed ID: 17066196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella enterica serotype Choleraesuis infections in pediatric patients.
    Chiu CH; Chuang CH; Chiu S; Su LH; Lin TY
    Pediatrics; 2006 Jun; 117(6):e1193-6. PubMed ID: 16717121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.